Lipid Metabolism Practice Questions

Q: What is mainly composed of triacylglycerols synthesized in intestinal epithelial cells?

Chylomicrons. **Explanation:** The correct answer is **Chylomicrons**. **1. Why Chylomicrons are correct:** Chylomicrons are the largest and least dense lipoproteins. They are synthesized exclusively in the **intestinal mucosal cells** (enterocytes) following the absorption of dietary fats. Their primary function is the transport of **exogenous (dietary) triacylglycerols (TAGs)** from the intestine to peripheral tissues like adipose tissue and muscle. They consist of approximately 85-90% triacylglycerols, making TAGs their predominant lipid component. **2. Why other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** While also rich in TAGs (approx. 60%), VLDL is synthesized in the **liver**, not the intestine. It transports **endogenous** triacylglycerols. * **LDL (Low-Density Lipoprotein):** Formed from VLDL metabolism, LDL is the primary carrier of **cholesterol** to peripheral tissues. It contains very little TAG. * **HDL (High-Density Lipoprotein):** Synthesized in both the liver and intestine, HDL is the smallest lipoprotein. It is primarily composed of **protein** and phospholipids and is involved in **reverse cholesterol transport**. **3. NEET-PG High-Yield Pearls:** * **Apolipoprotein Marker:** **Apo B-48** is the unique structural protein for chylomicrons (synthesized via RNA editing), whereas **Apo B-100** is the marker for VLDL and LDL. * **Rate-Limiting Enzyme:** Lipoprotein Lipase (LPL), activated by **Apo C-II**, clears TAGs from chylomicrons in the capillaries. * **Clinical Correlation:** **Abetalipoproteinemia** is a condition where a deficiency in Microsomal Triglyceride Transfer Protein (MTP) prevents the assembly of chylomicrons, leading to fat malabsorption and steatorrhea. * **Appearance:** Chylomicrons cause the "milky" appearance of plasma (chylous) after a fatty meal.

Q: Respiratory distress syndrome is due to a defect in the biosynthesis of which substance?

Dipalmitoyl lecithin. ### Explanation **Correct Option: A. Dipalmitoyl lecithin** **Mechanism and Concept:** Respiratory Distress Syndrome (RDS), also known as Hyaline Membrane Disease, is primarily caused by a deficiency of **pulmonary surfactant**. Surfactant is a surface-active lipoprotein complex secreted by **Type II pneumocytes**. Its primary function is to reduce surface tension at the air-liquid interface of the alveoli, preventing alveolar collapse (atelectasis) during expiration. The most critical functional component of surfactant is **Dipalmitoylphosphatidylcholine (DPPC)**, commonly known as **Dipalmitoyl lecithin**. It accounts for approximately 50–60% of the surfactant composition. Chemically, it is a phospholipid with two palmitic acid chains. A defect in its biosynthesis or premature birth (before 34 weeks) leads to high surface tension, decreased lung compliance, and subsequent respiratory failure. **Why Other Options are Incorrect:** * **B, C, and D:** While Cephalin (Phosphatidylethanolamine), Serine (Phosphatidylserine), and Inositol (Phosphatidylinositol) are all phospholipids found in cell membranes and in minor quantities within surfactant, they do not possess the unique surface-tension-reducing properties of lecithin. They are not the primary functional molecules whose deficiency leads to RDS. **High-Yield Clinical Pearls for NEET-PG:** * **L/S Ratio:** Fetal lung maturity is assessed by the **Lecithin-Sphingomyelin ratio** in amniotic fluid. A ratio **> 2.0** indicates mature lungs. * **Glucocorticoids:** Antenatal administration of steroids (e.g., Betamethasone or Dexamethasone) accelerates surfactant synthesis by inducing enzymes in Type II pneumocytes. * **Surfactant Proteins:** SP-A and SP-D are involved in innate immunity, while **SP-B and SP-C** are crucial for the physical properties of surfactant. * **Radiology:** RDS typically presents with a "ground-glass appearance" and air bronchograms on a chest X-ray.

Q: Which molecule serves as a marker for lipid peroxidation?

Malondialdehyde. ### Explanation **Correct Answer: D. Malondialdehyde (MDA)** **Concept:** Lipid peroxidation is a process where free radicals (Reactive Oxygen Species) attack polyunsaturated fatty acids (PUFAs) in cell membranes, leading to cell damage. This oxidative degradation results in the formation of reactive aldehydes. **Malondialdehyde (MDA)** is one of the most well-known secondary end-products of this process. Because MDA levels correlate directly with the degree of lipid damage, it is used clinically and experimentally as a reliable **biomarker for oxidative stress**. **Analysis of Incorrect Options:** * **A. Catalase:** This is an antioxidant enzyme that decomposes hydrogen peroxide ($H_2O_2$) into water and oxygen. It is a protective mechanism *against* oxidative stress, not a marker of the damage itself. * **B. Glutathione Reductase:** This enzyme regenerates reduced glutathione (GSH) from its oxidized form (GSSG) using NADPH. It is part of the cellular antioxidant defense system. * **C. Maltase:** This is a digestive enzyme (disaccharidase) found in the brush border of the small intestine that breaks down maltose into glucose. It has no role in lipid metabolism or oxidative stress. **High-Yield Clinical Pearls for NEET-PG:** * **TBARS Assay:** The Thiobarbituric Acid Reactive Substances (TBARS) test is the standard laboratory method used to measure MDA levels. * **Other Markers:** Apart from MDA, **4-hydroxynonenal (4-HNE)** and **Isoprostanes** (measured in urine) are also potent markers of lipid peroxidation. * **Vitamin E (Tocopherol):** It is the most important lipid-soluble antioxidant that prevents lipid peroxidation by acting as a chain-breaker in cell membranes. * **Pathology Link:** Lipid peroxidation is a key mechanism in atherosclerosis, reperfusion injury, and ionizing radiation damage.

Q: Which of the following statements is true about cholesterol?

It is amphipathic in nature.. **Explanation:** **Why Option D is Correct:** Cholesterol is an **amphipathic** molecule, meaning it possesses both hydrophilic (water-loving) and hydrophobic (water-fearing) properties. The single **hydroxyl (-OH) group** at position C3 provides the polar, hydrophilic head, while the bulky steroid nucleus and the hydrocarbon side chain constitute the non-polar, hydrophobic tail. This property is crucial for its role in cell membranes, where it inserts itself between phospholipids to regulate membrane fluidity. **Analysis of Incorrect Options:** * **Option A:** Cholesterol is a **27-carbon** compound (not 25). It is synthesized from acetyl-CoA via the mevalonate pathway. * **Option B:** The hydroxyl group is located at the **3rd carbon** (C3), not the 5th. There is, however, a double bond between the 5th and 6th carbons. * **Option C:** Cholesterol contains the **cyclopentanoperhydrophenanthrene (CPPP)** ring system (also known as the steroid nucleus). "Tetra-hydrophenanthrene" is an incomplete description of this complex four-ring structure. **High-Yield Facts for NEET-PG:** * **Rate-limiting enzyme:** HMG-CoA Reductase (inhibited by Statins). * **Precursor Role:** It is the parent compound for bile acids, steroid hormones (cortisol, estrogen, testosterone), and Vitamin D3. * **Excretion:** Humans cannot metabolize the cholesterol ring to $CO_2$ and $H_2O$; it is excreted primarily via bile as cholesterol or bile salts. * **Identification:** The **Libermann-Burchard reaction** is a classic chemical test for cholesterol (turns emerald green).

Q: What is required for beta-oxidation in the cytosol?

Acetyl CoA. **Explanation:** The core concept tested here is the **activation of fatty acids**, which is the prerequisite step for beta-oxidation. While the actual breakdown of fatty acids occurs within the mitochondrial matrix, the process begins in the **cytosol**. 1. **Why Acetyl CoA is correct:** Before a fatty acid can undergo beta-oxidation, it must be "activated" into **Fatty Acyl-CoA**. This reaction is catalyzed by the enzyme *Acyl-CoA synthetase* (Thiokinase) located on the outer mitochondrial membrane/cytosol. This process requires **ATP**, **Coenzyme A (CoA)**, and magnesium. Since Acetyl-CoA is essentially a carrier of the acetyl group and a source of Coenzyme A in various metabolic pools, it represents the necessity of the CoA moiety for the formation of the activated thioester bond. 2. **Why the other options are incorrect:** * **Pyruvate:** This is the end-product of glycolysis. While it can be converted to Acetyl-CoA inside the mitochondria via the PDH complex, it is not a direct requirement for the activation of fatty acids in the cytosol. * **Citrate:** Citrate acts as a carrier to move Acetyl-CoA *out* of the mitochondria for fatty acid **synthesis** (not oxidation). It also inhibits Phosphofructokinase-1 (PFK-1). * **Alpha-ketoglutarate:** This is an intermediate of the TCA cycle and is involved in nitrogen metabolism (transamination), having no direct role in the cytosolic activation of fatty acids. **High-Yield NEET-PG Pearls:** * **Carnitine Shuttle:** Once activated to Fatty Acyl-CoA in the cytosol, long-chain fatty acids require the Carnitine shuttle (CPT-I and CPT-II) to cross the inner mitochondrial membrane. * **Rate-Limiting Step:** CPT-I is the rate-limiting enzyme of beta-oxidation and is inhibited by **Malonyl-CoA** (an intermediate of fatty acid synthesis). * **Energy Yield:** The activation step "costs" the equivalent of **2 ATP** (ATP → AMP + PPi).

Q: All of the following are bile acids, EXCEPT:

Taurocholic acid. **Explanation:** The distinction between **bile acids** and **bile salts** is a high-yield concept in lipid metabolism. Bile acids are synthesized in the liver from cholesterol, while bile salts are the conjugated forms of these acids. **Why Taurocholic acid is the correct answer:** Taurocholic acid is a **bile salt**, not a bile acid. In the liver, primary bile acids are conjugated with amino acids—either **Glycine** or **Taurine**—to form bile salts (e.g., Glycocholic acid or Taurocholic acid). Conjugation lowers the pKa of the molecules, making them more ionized and effective detergents at intestinal pH, which is essential for lipid emulsification. **Analysis of incorrect options:** * **Chenodeoxycholic acid (Option D):** This is a **primary bile acid**, synthesized directly from cholesterol in the liver (along with Cholic acid). * **Deoxycholic acid (Option C) & Lithocholic acid (Option A):** These are **secondary bile acids**. They are formed in the intestine by the action of bacterial enzymes (7-α-dehydroxylase) on primary bile acids. Cholic acid becomes Deoxycholic acid, and Chenodeoxycholic acid becomes Lithocholic acid. **NEET-PG High-Yield Pearls:** * **Rate-limiting enzyme:** Cholesterol 7-α-hydroxylase (inhibited by bile acids via feedback). * **Enterohepatic circulation:** 95% of bile salts are reabsorbed in the **terminal ileum** and returned to the liver. * **Steatorrhea:** Occurs if bile acid synthesis is impaired or if the terminal ileum is resected (Crohn’s disease), leading to fat malabsorption. * **Primary vs. Secondary:** Primary are made in the *Liver*; Secondary are made in the *Gut* (by bacteria).

Q: All of the following are Isoprene derivatives (Polyprenoids), except?

Ubiquitin. **Explanation:** The question tests your ability to distinguish between **Isoprenoids (Polyprenoids)**—lipids synthesized from 5-carbon isoprene units—and unrelated proteins with similar names. **1. Why Ubiquitin is the Correct Answer:** **Ubiquitin** is a small **regulatory protein** (76 amino acids) found in all eukaryotic cells. Its primary function is to tag misfolded or unneeded proteins for degradation via the Proteasome pathway (Ubiquitin-Proteasome System). Despite the phonetic similarity to *Ubiquinone*, it is **not** a lipid or an isoprene derivative. **2. Analysis of Incorrect Options (Isoprene Derivatives):** Isoprenoids are formed from the condensation of isopentenyl pyrophosphate (IPP) units. * **Dolichol:** A long-chain isoprenoid alcohol (containing up to 20 isoprene units) required for the synthesis of N-linked glycoproteins in the Endoplasmic Reticulum. * **Beta-carotene:** A tetraterpene (8 isoprene units) that serves as a precursor to Vitamin A. * **Alpha-tocopherol (Vitamin E):** A fat-soluble vitamin containing a chromanol ring and an **isoprenoid side chain**. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Ubiquinone (Coenzyme Q10):** Do not confuse this with Ubiquitin. Ubiquinone is a component of the Electron Transport Chain and **is** an isoprene derivative. * **Cholesterol Synthesis:** The precursor for all human isoprenoids is **Mevalonate**, which is formed by the rate-limiting enzyme **HMG-CoA Reductase**. * **Other Isoprenoids:** Include Vitamins A, D, E, K, and bile acids. * **Statin Mechanism:** Statins inhibit HMG-CoA Reductase, which not only lowers cholesterol but also reduces levels of Dolichol and Ubiquinone (explaining some side effects like myopathy).

Q: A patient with hyperlipoproteinemia would most likely benefit from a low-carbohydrate diet if the elevated lipoproteins in the blood belong to which class?

VLDL. **Explanation:** The correct answer is **VLDL (Very Low-Density Lipoprotein)**. **Why VLDL is the correct answer:** VLDL is synthesized in the liver, primarily from endogenous triglycerides. A high intake of dietary carbohydrates leads to an excess of glucose, which is converted into fatty acids via **de novo lipogenesis**. These fatty acids are then esterified into triglycerides and packaged into VLDL particles for transport. Therefore, a **low-carbohydrate diet** directly reduces the substrate available for hepatic triglyceride synthesis, effectively lowering VLDL levels in the blood. This is particularly relevant in Type IV Hyperlipoproteinemia. **Why the other options are incorrect:** * **Chylomicrons:** These transport **exogenous (dietary) lipids** from the intestines. To lower chylomicrons, a patient would benefit from a **low-fat diet**, not necessarily a low-carbohydrate diet. * **LDL:** LDL is the "bad cholesterol" derived from the catabolism of VLDL. While lowering VLDL can eventually lower LDL, the primary dietary intervention for isolated high LDL is reducing **saturated fats and cholesterol** intake. * **HDL:** HDL is "good cholesterol" involved in reverse cholesterol transport. Low-carbohydrate diets do not typically aim to lower HDL; in fact, increasing HDL is clinically desirable. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme for Lipogenesis:** Acetyl-CoA Carboxylase (stimulated by Insulin, which rises with carb intake). * **Apolipoprotein marker for VLDL:** Apo B-100. * **Friedewald Formula:** LDL = Total Cholesterol – (HDL + VLDL). Note: VLDL is estimated as Triglycerides/5 (if TG <400 mg/dL). * **Type IV Hyperlipoproteinemia:** Characterized by isolated elevation of VLDL; it is highly sensitive to dietary carbohydrates and alcohol.

Q: A 8-year-old child presents with a history since early childhood of malabsorption, ataxia, acanthocytes in the peripheral blood, and very low cholesterol and triglyceride levels. The patient has also developed progressive, bilateral, concentric contraction of the visual fields and loss of central vision. What is the underlying pathogenesis of this patient's disease?

A defect in the synthesis of apolipoprotein B. **Explanation:** The clinical presentation of malabsorption, ataxia, acanthocytosis (star-shaped RBCs), and extremely low lipid levels in a child is diagnostic of **Abetalipoproteinemia** (Bassen-Kornzweig syndrome). **1. Why the Correct Answer is Right:** The underlying pathogenesis is a mutation in the **Microsomal Triglyceride Transfer Protein (MTP)** gene. MTP is essential for loading lipids onto **Apolipoprotein B (Apo B)**. A defect here leads to an inability to synthesize and secrete Apo B-containing lipoproteins: **Apo B-48** (required for Chylomicron assembly in enterocytes) and **Apo B-100** (required for VLDL assembly in the liver). This results in fat malabsorption, failure to thrive, and a near-total absence of VLDL, LDL, and Chylomicrons in plasma. The neurological and visual symptoms (retinitis pigmentosa) are due to severe deficiency of fat-soluble vitamins, particularly **Vitamin E**. **2. Why Incorrect Options are Wrong:** * **Option A & C:** While cerebellar ataxia and degeneration of spinal tracts occur, these are **secondary manifestations** of chronic Vitamin E deficiency, not the primary pathogenesis. * **Option D:** Absence of HDL is characteristic of **Tangier Disease** (ABCA1 defect). In Abetalipoproteinemia, HDL levels may be low but are present; it is the Apo B-containing fractions that are absent. **High-Yield Clinical Pearls for NEET-PG:** * **Biochemical Hallmark:** Near-zero levels of LDL and VLDL; Cholesterol <50 mg/dL. * **Peripheral Smear:** **Acanthocytes** (spur cells) due to altered RBC membrane lipid composition. * **Intestinal Biopsy:** Enterocytes appear "clear" or vacuolated because they are **loaded with triglycerides** that cannot be exported as chylomicrons. * **Treatment:** High-dose oral Vitamin E and restriction of long-chain fatty acids.

Q: Which of the following lipoproteins has the maximum density?

HDL. **Explanation:** The density of a lipoprotein is determined by its **protein-to-lipid ratio**. Proteins are significantly denser than lipids; therefore, the higher the protein content and the lower the lipid content, the higher the density of the particle. **1. Why HDL is correct:** **High-Density Lipoprotein (HDL)** contains the highest percentage of protein (approx. 40–55%) and the lowest percentage of lipids among all lipoproteins. Because it is the smallest and most protein-rich particle, it has the maximum density (1.063–1.210 g/mL). **2. Why the other options are incorrect:** * **Chylomicrons:** These have the **lowest density** (<0.95 g/mL) because they are composed of ~98% lipids (primarily dietary triglycerides) and very little protein. They are the largest in size. * **VLDL (Very Low-Density Lipoprotein):** These are rich in endogenous triglycerides. While denser than chylomicrons, they still have a high lipid-to-protein ratio. * **LDL (Low-Density Lipoprotein):** Formed from VLDL, LDL is rich in cholesterol. It is denser than VLDL but significantly less dense than HDL. **High-Yield NEET-PG Pearls:** * **Order of Density (Lowest to Highest):** Chylomicrons VLDL > IDL > LDL > HDL. (Density and Size are inversely proportional). * **Electrophoretic Mobility:** On electrophoresis (at pH 8.6), the mobility from origin is: **HDL (Alpha) > VLDL (Pre-beta) > LDL (Beta) > Chylomicrons (Origin).** * **Apolipoprotein Marker:** HDL is characterized by **Apo A-I**, which activates LCAT for reverse cholesterol transport.

Question 1

What is mainly composed of triacylglycerols synthesized in intestinal epithelial cells?

Accepted Answer

Chylomicrons

Answer

VLDL

Answer

LDL

Answer

HDL

Question 2

Respiratory distress syndrome is due to a defect in the biosynthesis of which substance?

Accepted Answer

Dipalmitoyl lecithin

Answer

Dipalmitoyl cephalin

Answer

Dipalmitoyl serine

Answer

Dipalmitoyl inositol

Question 3

Which molecule serves as a marker for lipid peroxidation?

Accepted Answer

Malondialdehyde

Answer

Catalase

Answer

Glutathione reductase

Answer

Maltase

Question 4

Which of the following statements is true about cholesterol?

Accepted Answer

It is amphipathic in nature.

Answer

It is made up of 25 carbons.

Answer

It has a hydroxyl group at the 5th carbon.

Answer

It contains the cyclic tetra-hydrophenanthrene ring.

Question 5

What is required for beta-oxidation in the cytosol?

Accepted Answer

Acetyl CoA

Answer

Pyruvate

Answer

Citrate

Answer

Alpha-ketoglutarate

Question 6

All of the following are bile acids, EXCEPT:

Accepted Answer

Taurocholic acid

Answer

Lithocholic acid

Answer

Deoxycholic acid

Answer

Chenodeoxycholic acid

Question 7

All of the following are Isoprene derivatives (Polyprenoids), except?

Accepted Answer

Ubiquitin

Answer

Dolichol

Answer

beta-carotene

Answer

alpha-tocopherol

Question 8

A patient with hyperlipoproteinemia would most likely benefit from a low-carbohydrate diet if the elevated lipoproteins in the blood belong to which class?

Accepted Answer

VLDL

Answer

Chylomicrons

Answer

LDL

Answer

HDL

Question 9

A 8-year-old child presents with a history since early childhood of malabsorption, ataxia, acanthocytes in the peripheral blood, and very low cholesterol and triglyceride levels. The patient has also developed progressive, bilateral, concentric contraction of the visual fields and loss of central vision. What is the underlying pathogenesis of this patient's disease?

Accepted Answer

A defect in the synthesis of apolipoprotein B

Answer

A degenerative disease involving the cerebellum

Answer

Degeneration of the posterior columns, spinocerebellar tracts, and corticospinal tracts

Answer

An absence of high-density lipoproteins

Question 10

Which of the following lipoproteins has the maximum density?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

Chylomicrons

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?